ADHERENCE AND PERSISTENCE OF ORAL ANTICOAGULANTS FOR TREATMENT OF ATRIAL FIBRILLATION ACROSS STROKE AND BLEEDING RISK STRATA

被引：0
|
作者：
Ko, G. [1 ]
Brouwer, E. [2 ]
Dayer, V [3 ]
Katta, A. [4 ]
Ramsey, S. [2 ]
Lopes, M. [5 ]
Singh, R. [1 ]
Kong, S. X. [1 ]
机构：
[1] Bayer US LLC, Whippany, NJ USA
[2] Curta Inc, Seattle, WA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Bayer Healthcare Pharmaceut Inc, Jersey City, NJ USA
[5] MMDLOPES LLC, Cresskill, NJ USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR233
引用
收藏
页码：S339 / S339
页数：1
相关论文
共 50 条
  • [21] Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
    Senoo, Keitaro
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    CURRENT PROBLEMS IN CARDIOLOGY, 2014, 39 (09) : 319 - 344
  • [22] Effect of Discontinuation and Nonadherence to Oral Anticoagulants on Atrial Fibrillation Stroke Risk
    Yao, Xiaoxi
    Abraham, Neena S.
    Noseworthy, Peter A.
    Alexander, G. Caleb
    Sangaralingham, Lindsey R.
    Shah, Nilay D.
    CIRCULATION, 2015, 132
  • [23] Risk of stroke in hypertensive patients with atrial fibrillation treated with oral anticoagulants
    Harskamp, R. E.
    Lucassen, W. A. M.
    Lopes, R. D.
    Van Weert, H. C.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3709 - 3709
  • [24] Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk
    Chao, Tze-Fan
    Chan, Yi-Hsin
    Chiang, Chern-En
    Tuan, Ta-Chuan
    Liao, Jo-Nan
    Chen, Tzeng-Ji
    Lip, Gregory Y. H.
    Chen, Shih-Ann
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (07) : 730 - 738
  • [25] Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation
    Beyer-Westendorf, Jan
    Ehlken, Birgit
    Evers, Thomas
    EUROPACE, 2016, 18 (08): : 1150 - 1157
  • [26] Racial Disparity in the Prescription of Anticoagulants and Risk of Stroke and Bleeding in Atrial Fibrillation Patients
    Tedla, Yacob G.
    Schwartz, Sarah M.
    Silberman, Philip
    Greenland, Philip
    Passman, Rod S.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (05):
  • [27] Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey
    Obamiro, Kehinde O.
    Chalmers, Leanne
    Lee, Kenneth
    Bereznicki, Bonnie J.
    Bereznicki, Luke R.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 23 (04) : 337 - 343
  • [28] Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding
    Lip, Gregory Y. H.
    Keshishian, Allison, V
    Zhang, Yan
    Kang, Amiee
    Dhamane, Amol D.
    Luo, Xuemei
    Klem, Christian
    Ferri, Mauricio
    Jiang, Jenny
    Yuce, Huseyin
    Deitelzweig, Steven
    JAMA NETWORK OPEN, 2021, 4 (08) : E2120064
  • [29] Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation
    Overvad, Thure F.
    Larsen, Torben B.
    Albertsen, Ida E.
    Rasmussen, Lars H.
    Lip, Gregory Y. H.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (12) : 1619 - 1629
  • [30] Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation
    Xu, Yunwen
    Chang, Alex R.
    Inker, Lesley A.
    McAdams-DeMarco, Mara
    Grams, Morgan E.
    Shin, Jung-Im
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (14):
12345